Keith Quirolo, MD
Clinical Director of Apheresis, Division of
Residency: Children’s Hospital & Research Center Oakland
Fellowship: Transfusion Medicine, University of California, San Francisco
Board Certification: Pediatrics
Keith Quirolo, MD, is an expert on sickle cell disease and thalassemia. Children’s Hospital & Research Center Oakland has the largest sickle cell program in the western United States. Children’s sees 500 patients, children and adults, from various states every year—about 2,000 outpatient visits a year. Dr. Quirolo is the author or co-author of 14 peer-reviewed journal articles and a frequent speaker on sickle cell disease and transfusion. He serves on the Blood Advisory Committee of the Center for Biologics Evaluation and Research, part of the Food and Drug Administration (FDA). This committee approved Exjade in 2005, the first oral iron-chelator that removes excess iron, and advises the FDA on blood transfusion science.
Sickle cell disease is an inherited blood disorder. Adults who carry the trait are at risk of having children with the disease. In the United States, 1 in 12 African Americans and 1 in 180 Latinos are at risk of carrying the sickle cell trait(1). More than 72,000 people in the U.S have the disease and about 2 million Americans carry the trait(2).
During apheresis blood is removed from a donor or patient and passed through an apparatus that removes one particular element and returns what remains to the donor or patient.
Professional and Personal background
You can reach this physician by contacting Media Relations.